ethidium has been researched along with gq1b ganglioside in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Halstead, SK; Humphreys, PD; Morgan, BP; Morrison, DB; O'Hanlon, GM; Plomp, JJ; Todd, AJ; Willison, HJ | 1 |
1 other study(ies) available for ethidium and gq1b ganglioside
Article | Year |
---|---|
Anti-disialoside antibodies kill perisynaptic Schwann cells and damage motor nerve terminals via membrane attack complex in a murine model of neuropathy.
Topics: Animals; Antibodies; CD59 Antigens; Cell Death; Cells, Cultured; Complement Activation; Complement Membrane Attack Complex; Complement System Proteins; Ethidium; Gangliosides; Humans; Immunization, Passive; Intercalating Agents; Male; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; Microscopy, Immunoelectron; Motor Neurons; Nerve Growth Factors; Nervous System Autoimmune Disease, Experimental; Neuromuscular Junction; Schwann Cells | 2004 |